Skip to main content
Fig. 1 a | BMC Chemistry

Fig. 1 a

From: Chromatographic analysis of triple cough therapy; bromhexine, guaiafenesin and salbutamol and pharmaceutical impurity: in-silico toxicity profile of drug impurity

Fig. 1 a

2D-TLC densitogram of a standard mixture of Salbutamol, Guaiafenesin, Guaiacol and Bromhexine, (Rf SAL: 0.07, Rf GUF: 0.29, Rf GUL: 0.76, and Rf BR: 0.92). b 2D-TLC densitogram of ventocough® syrup (with sugar) containing Salbutamol, Guaiafenesin, Bromhexine, and excipients, (Rf SAL: 0.07, Rf Excipients: 0.21, Rf GUL: 0.76, and Rf BR: 0.92). c 2D-TLC densitogram of ventocough® syrup (without sugar) containing Salbutamol, Guaiafenesin, Bromhexine, and Excipients, (Rf SAL: 0.07, Rf Excipients: 0.21, Rf GUL: 0.76, and Rf BR: 0.92)

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us